Acute Angiographic and Intermediate-Term Clinical Results of Patients with Non-Left Main Coronary Bifurcation Lesions Treated with BVS by Jailed Semi-Inflated Balloon Technique and Provisional Side-Branch Stenting Strategy

Chieh-Shou Su, Keng-Hao Chang, Chih‐Hung Lai, Yuwei Chen, Tzu-Hsiang Lin, Hung-Chih Pan, Tsun-Jui Liu, Wen-Lieng LeeJournal of Interventional Cardiology 2019 · DOI

TL;DR

This study investigates a novel technique, the "jailed semi-inflated balloon technique" (JSIBT), for protecting side branches during stenting of complex coronary artery bifurcations. The findings suggest JSIBT is a safe and effective method for use with bioresorbable vascular scaffolds (BVS), offering comparable results to traditional drug-eluting stents (DES) in terms of both immediate angiographic outcomes and intermediate-term clinical results.

What Problem Does This Paper Address?

Coronary artery bifurcation disease (CABD) is a common and challenging condition, accounting for 15-20% of percutaneous coronary interventions (PCI). The complexity arises from the need to treat lesions at the junction of two major coronary arteries, where stenting one vessel can inadvertently compromise the other (the side branch, SB). While the provisional side-branch stenting strategy is standard, there's a significant risk of acute SB occlusion, especially in complex lesions. Traditional methods to protect the SB during main vessel (MV) stenting, like the jailed balloon technique (JBT) and JSIBT, have been developed for DES. However, the introduction of bioresorbable vascular scaffolds (BVS), which have thicker struts and require higher post-dilation pressures, raised concerns about SB protection. This paper addresses the lack of data on the efficacy of JSIBT specifically for BVS in complex CABD cases.

Methods

The study employed a retrospective, case-cohort design, analyzing data from 68 patients with non-left main CABD treated between January 2015 and December 2017. Patients were divided into two groups: 20 treated with BVS and 48 with DES, both using the JSIBT for SB protection. The JSIBT procedure involves wiring both the MV and SB, predilating both, advancing the MV stent/scaffold, and then inserting a semi-inflated balloon into the SB, with the balloon's proximal portion protruding into the MV. This "jailed" balloon is inflated at low pressure during MV stent/scaffold deployment. After MV stent/scaffold inflation, the SB balloon is deflated and removed. Proximal optimal technique (POT) was used for optimization. The study compared baseline demographics, interventional details, and in-hospital and intermediate-term clinical outcomes between the BVS and DES groups.

Datasets

Not discussed in the paper. The study utilized patient data collected retrospectively from the Taichung Veterans General Hospital's hospital database.

Key Insights and Ideas

  • JSIBT is Adaptable to BVS: The study demonstrates that JSIBT, initially developed for DES, can be safely and effectively applied to protect SBs when using BVS, even with BVS's thicker struts.
  • Comparable Outcomes: Despite concerns about BVS, the JSIBT technique yielded comparable acute angiographic results and intermediate-term clinical outcomes (target lesion failure, revascularization, myocardial infarction, and death) between the BVS and DES groups.
  • SB Protection is Crucial: The paper reinforces the importance of robust SB protection strategies in complex CABD, highlighting that even with modern devices, risks of SB compromise exist.
  • Potential for BVS in Complex Cases: The findings suggest that with appropriate techniques like JSIBT, BVS can be a viable option for complex bifurcation lesions, potentially offering advantages in long-term vessel remodeling.

Key Results

  • SB Complications: No SB balloon rupture or entrapment occurred in either group. The incidence of SB dissection/occlusion and the need for SB rewiring or stenting were low and not significantly different between the BVS (20% dissection, 10% rewiring) and DES (8.3% dissection, 18.8% rewiring) groups.
  • Angiographic Improvement: Post-interventional TIMI flow significantly increased in both MV and SB in both groups.
  • Clinical Outcomes: In-hospital death rates were similar. Clinical follow-up (median 1.8 years for BVS, 1.3 years for DES) showed no significant differences in target lesion failure (TLF), target lesion revascularization (TLR), target vessel revascularization (TVR), myocardial infarction (MI), or all-cause death between the groups.
  • Patient Characteristics: The BVS group was younger and had higher BMI, total cholesterol, LDL-C, and hemoglobin, but lower serum creatinine and a lower prevalence of prior PCI and MI compared to the DES group.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: The study was non-randomized and retrospective, limiting definitive causal conclusions.
  • Small Sample Size: The study population in both groups was relatively small, particularly the BVS group, due to the relatively recent introduction of BVS and the specific application of JSIBT.
  • Lack of Imaging: Optical coherence tomography (OCT) or intravascular ultrasound (IVUS) were not routinely performed, which could provide more detailed insights into scaffold apposition and neointimal coverage.

Future work should involve larger, prospective, randomized trials with imaging modalities to further validate these findings and confirm the long-term clinical value of JSIBT with BVS in complex CABD. The authors also suggest that this technique could be applicable to other bioresorbable scaffolds and potentially adapted for other complex lesion scenarios.

Summary updated

Abstract

The use of JSIBT for treating CABD with modern BVS can provide SB protection as similar as those with DES, even with higher incidence of acute SB dissection/occlusion. The immediate angiographic results and acute and intermediate-term clinical outcomes were also similar in both groups. Our study results demonstrate that JSIBT might be a safe and alternative SB protection tool for BVS in patients with complex CABD.
BibTeX
@article{su2019acute,
  author = {Chieh-Shou Su and Keng-Hao Chang and Chih‐Hung Lai and Yuwei Chen and Tzu-Hsiang Lin and Hung-Chih Pan and Tsun-Jui Liu and Wen-Lieng Lee},
  title = {{Acute Angiographic and Intermediate-Term Clinical Results of Patients with Non-Left Main Coronary Bifurcation Lesions Treated with BVS by Jailed Semi-Inflated Balloon Technique and Provisional Side-Branch Stenting Strategy}},
  journal = {Journal of Interventional Cardiology},
  year = {2019},
  doi = {10.1155/2019/9896267},
}
Figure